Alembic Pharmaceuticals commissioned a new formulations manufacturing facility in Pithampur, Madhya Pradesh, marking a major step forward in its strategic business expansion. Alembic Pharmaceuticals funded the facility, built with an investment of approximately ₹205 crore, through a mix of internal accruals and borrowings.
Driving In-House Production and Efficiency
Alembic Pharmaceuticals set up the facility to support business growth and transition third-party products into in-house manufacturing. Alembic’s existing multiple formulations plants have been operating at near-optimal capacity, prompting the need for additional infrastructure to meet rising demand.
The Pithampur facility will significantly enhance Alembic’s manufacturing capabilities, giving the company better control over production timelines, quality, and costs.
Building for the Future
By investing in advanced infrastructure and consolidating its production capabilities, Alembic aims to improve operational efficiency, enhance product availability, and boost supply chain reliability.
As reported by projectstoday.com, the expansion reflects the company’s strong commitment to scaling operations in an increasingly competitive pharmaceutical landscape, while maintaining the highest standards of quality and excellence.
